Event: 2026 DIA Medical Affairs and Scientific Communications
Date: Mar 2-4, 2026
Location: The Westin Boston Seaport District（425 Summer Street, Boston, MA 02210, USA）
The DIA Medical Affairs and Scientific Communications Forum is a premier multidisciplinary platform designed by and for medical affairs professionals. Spanning three specialized tracks—Medical Communications, Medical Writing, and Field Medical—the forum focuses on fostering interdepartmental collaboration and strategic synergy. Attendees gain critical insights into evolving regulatory compliance and communication trends, equipping them with actionable knowledge to navigate the complex challenges and daily responsibilities of the modern medical affairs landscape.
Booth Number: 200
Presentation from AlphaLife Sciences:
Date: TBD
Time: TBD
Speaker: William Chen, Principal Business Solution Architect, AlphaLife Sciences
Topic: How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control
In this session, William Chen, Principal Business Solution Architect at AlphaLife Sciences, will demonstrate how AuroraPrime, a purpose-built GenAI platform, is bridging the gap between raw clinical data and submission-ready assets. We will move beyond the hype of generic LLMs to showcase Agentic AI workflows that integrate seamlessly with RIM systems and Veeva Vault.
The presentation will focus on three key areas critical to the RSIDM community:
Structured Content Transformation: How AI agents automate the drafting of complex Module 2 (e.g., Clinical Overviews) and Module 5 documents directly from source TFLs, ensuring strict adherence to granular regulatory templates.
Traceability & Data Integrity: detailed look at AlphaLife’s proprietary "Traceability Framework", which links every AI-generated claim back to the source data, enabling instant verification and mitigating hallucination risks.
Automated Compliance Checks: Leveraging AI to perform automated pre-submission QC (e.g., style formatting, terminology consistency) to reduce the "kick-back" rate during the publishing phase.
Join us to explore how a "Human-in-the-loop" AI strategy can reduce first-draft authoring time by 50-90%, allowing regulatory teams to shift focus from operational assembly to strategic submission management.
To request a meeting, fill out the form provided and a representative will be in contact soon to schedule.
